<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39331333</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2197-425X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Intensive care medicine experimental</Title><ISOAbbreviation>Intensive Care Med Exp</ISOAbbreviation></Journal><ArticleTitle>Multiomic biomarkers after cardiac arrest.</ArticleTitle><Pagination><StartPage>83</StartPage><MedlinePgn>83</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">83</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40635-024-00675-y</ELocationID><Abstract><AbstractText>Cardiac arrest is a sudden cessation of heart function, leading to an abrupt loss of blood flow and oxygen to vital organs. This life-threatening emergency requires immediate medical intervention and can lead to severe neurological injury or death. Methods and biomarkers to predict neurological outcome are available but lack accuracy. Such methods would allow personalizing healthcare and help clinical decisions. Extensive research has been conducted to identify prognostic omic biomarkers of cardiac arrest. With the emergence of technologies allowing to combine different levels of omics data, and with the help of artificial intelligence and machine learning, there is a potential to use multiomic signatures as prognostic biomarkers after cardiac arrest. This review article delves into the current knowledge of cardiac arrest biomarkers across various omic fields and suggests directions for future research aiming to integrate multiple omics data layers to improve outcome prediction and cardiac arrest patient's care.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stopa</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, 1A-B rue Edison, 1445, Strassen, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lileikyte</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Anaesthesia and Intensive Care, Lund University, Helsingborg Hospital, Svart-brödragränden 3, 251 87, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakochi</LastName><ForeName>Anahita</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Swedish National Infrastructure for Biological Mass Spectrometry (BioMS), Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Infection Medicine, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agarwal</LastName><ForeName>Prasoon</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Science for Life Laboratory, Division of Occupational and Environmental Medicine, Department of Laboratory Medicine, National Bioinformatics Infrastructure Sweden (NBIS), Lund University, 22362, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beske</LastName><ForeName>Rasmus</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stammet</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Anesthesia and Intensive Care Medicine, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Life Sciences and Medicine, Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-Sur-Alzette, Luxembourg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassager</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Årman</LastName><ForeName>Filip</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Swedish National Infrastructure for Biological Mass Spectrometry (BioMS), Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nielsen</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Anaesthesia and Intensive Care, Lund University, Helsingborg Hospital, Svart-brödragränden 3, 251 87, Helsingborg, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Devaux</LastName><ForeName>Yvan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-5321-8543</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, 1A-B rue Edison, 1445, Strassen, Luxembourg. yvan.devaux@lih.lu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>101016072</GrantID><Agency>Horizon 2020 Framework Programme</Agency><Country /></Grant><Grant><GrantID>C14/BM/8225223</GrantID><Agency>Fonds National de la Recherche Luxembourg</Agency><Country /></Grant><Grant><GrantID>C17/BM/11613033</GrantID><Agency>Fonds National de la Recherche Luxembourg</Agency><Country /></Grant><Grant><GrantID>COVID-19/2020-1/14719577/miRCOVID</GrantID><Agency>Fonds National de la Recherche Luxembourg</Agency><Country /></Grant><Grant><GrantID>YMCA project</GrantID><Agency>Heart Foundation-Daniel Wagner</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Intensive Care Med Exp</MedlineTA><NlmUniqueID>101645149</NlmUniqueID><ISSNLinking>2197-425X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Biomarkers</Keyword><Keyword MajorTopicYN="N">Cardiac arrest</Keyword><Keyword MajorTopicYN="N">Clinical outcomes</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Multiomics</Keyword><Keyword MajorTopicYN="N">Prognosis</Keyword></KeywordList><CoiStatement>Y.D. holds patents and licensing agreements related to the use of RNAs for diagnostic and therapeutic purposes, and is member of the Scientific Advisory Board of Firalis SA. Other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39331333</ArticleId><ArticleId IdType="pmc">PMC11436561</ArticleId><ArticleId IdType="doi">10.1186/s40635-024-00675-y</ArticleId><ArticleId IdType="pii">10.1186/s40635-024-00675-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Dion Stub SB, Duffy SJ, Kaye DM (2011) Post cardiac arrest syndrome. Circulation 123:1428–1435</Citation><ArticleIdList><ArticleId IdType="pubmed">21464058</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Sandroni C, Böttiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VR (2021) European resuscitation council and European society of intensive care medicine guidelines 2021: post-resuscitation care. Resuscitation 161:220–269</Citation><ArticleIdList><ArticleId IdType="pubmed">33773827</ArticleId></ArticleIdList></Reference><Reference><Citation>Wihersaari L, Tiainen M, Skrifvars MB, Bendel S, Kaukonen K-M, Vaahersalo J, Romppanen J, Pettilä V, Reinikainen M (2019) Usefulness of neuron specific enolase in prognostication after cardiac arrest: Impact of age and time to ROSC. Resuscitation 139:214–221</Citation><ArticleIdList><ArticleId IdType="pubmed">31022497</ArticleId></ArticleIdList></Reference><Reference><Citation>Streitberger KJ, Leithner C, Wattenberg M, Tonner PH, Hasslacher J, Joannidis M, Pellis T, Di Luca E, Födisch M, Krannich A, Ploner CJ (2017) Neuron-specific enolase predicts poor outcome after cardiac arrest and targeted temperature management: a multicenter study on 1,053 patients. Critical Care Med 45(7):1145–1151</Citation><ArticleIdList><ArticleId IdType="pubmed">28426467</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummins RO, Ornato JP, Thies WH, Pepe PE (1991) Improving survival from sudden cardiac arrest: the “chain of survival” concept. A statement for health professionals from the advanced cardiac life support subcommittee and the emergency cardiac care committee. Am Heart Assoc Circ 83:1832–1847</Citation><ArticleIdList><ArticleId IdType="pubmed">2022039</ArticleId></ArticleIdList></Reference><Reference><Citation>Rankin J (1957) Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2:200–215</Citation><ArticleIdList><ArticleId IdType="pubmed">13432835</ArticleId></ArticleIdList></Reference><Reference><Citation>Haywood K, Whitehead L, Nadkarni VM, Achana F, Beesems S, Böttiger BW, Brooks A, Castrén M, Ong MEH, Hazinski MF, Koster RW, Lilja G, Long J, Monsieurs KG, Morley PT, Morrison L, Nichol G, Oriolo V, Saposnik G, Smyth M, Spearpoint K, Williams B, Perkins GD (2018) COSCA (Core outcome set for cardiac arrest) in adults: an advisory statement from the international liaison committee on resuscitation. Circulation 137:e783–e801</Citation><ArticleIdList><ArticleId IdType="pubmed">29700122</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayeux R (2004) Biomarkers: potential uses and limitations. NeuroRx 1:182–188</Citation><ArticleIdList><ArticleId IdType="pmc">PMC534923</ArticleId><ArticleId IdType="pubmed">15717018</ArticleId></ArticleIdList></Reference><Reference><Citation>F-NBW G (2016) BEST (biomarkers, endpoints, and other tools) resource. In: Editor (ed)^(eds) Book BEST (biomarkers, endpoints, and other tools) resource. Silver Spring MD and Bethesda, MD, City</Citation></Reference><Reference><Citation>Bodaghi A, Fattahi N, Ramazani A (2023) Biomarkers: promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases. Heliyon. 10.1016/j.heliyon.2023.e13323</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9884646</ArticleId><ArticleId IdType="pubmed">36744065</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasan RS (2006) Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 113:2335–2362</Citation><ArticleIdList><ArticleId IdType="pubmed">16702488</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmstrom L, Chaudhary NS, Nakamura K, Chugh H, Uy-Evanado A, Norby F, Metcalf GA, Menon VK, Yu B, Boerwinkle E, Chugh SS, Akdemir Z, Kransdorf EP (2023) Rare genetic variants associated with sudden cardiac arrest in the young: a prospective, population-based study. Circ Genom Precis Med 16:404–405</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10524160</ArticleId><ArticleId IdType="pubmed">37194601</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M (2005) Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102:10604–10609</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1174919</ArticleId><ArticleId IdType="pubmed">16009939</ArticleId></ArticleIdList></Reference><Reference><Citation>Moutinho C, Esteller M (2017) MicroRNAs and epigenetics. Adv Cancer Res 135:189–220</Citation><ArticleIdList><ArticleId IdType="pubmed">28882223</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauracher LM, Buchtele N, Schorgenhofer C, Weiser C, Herkner H, Merrelaar A, Spiel AO, Hell L, Ay C, Pabinger I, Jilma B, Schwameis M (2019) Increased citrullinated histone H3 levels in the early post-resuscitative period are associated with poor neurologic function in cardiac arrest survivors-a prospective observational study. J Clin Med 8:1568</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6832426</ArticleId><ArticleId IdType="pubmed">31581493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Bae SC (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3:166–179</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3056563</ArticleId><ArticleId IdType="pubmed">21416059</ArticleId></ArticleIdList></Reference><Reference><Citation>Oh JS, Tulasi J, Xiaodan R, Stacey WC, Neumar RW (2017) Valproic acid combined with postcardiac arrest hypothermic-targeted temperature management prevents delayed seizures and improves survival in a rat cardiac arrest model. Crit Care Med 45:e1149–e1156</Citation><ArticleIdList><ArticleId IdType="pubmed">28857853</ArticleId></ArticleIdList></Reference><Reference><Citation>Stammet P, Goretti E, Vausort M, Zhang L, Wagner DR, Devaux Y (2012) Circulating microRNAs after cardiac arrest. Crit Care Med 40:3209–3214</Citation><ArticleIdList><ArticleId IdType="pubmed">22890253</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wise MP, Aneman A, Al-Subaie N, Boesgaard S, Bro-Jeppesen J, Brunetti I, Bugge JF, Hingston CD, Juffermans NP, Koopmans M, Kober L, Langorgen J, Lilja G, Moller JE, Rundgren M, Rylander C, Smid O, Werer C, Winkel P, Friberg H, Investigators TTMT (2013) Targeted temperature management at 33 degrees C versus 36 degrees C after cardiac arrest. N Engl J Med 369:2197–2206</Citation><ArticleIdList><ArticleId IdType="pubmed">24237006</ArticleId></ArticleIdList></Reference><Reference><Citation>Beske RP, Bache S, Abild Stengaard Meyer M, Kjaergaard J, Bro-Jeppesen J, Obling L, Olsen MH, Rossing M, Nielsen FC, Moller K, Nielsen N, Hassager C (2022) MicroRNA-9-3p: a novel predictor of neurological outcome after cardiac arrest. Eur Heart J Acute Cardiovasc Care 11:609–616</Citation><ArticleIdList><ArticleId IdType="pubmed">35695264</ArticleId></ArticleIdList></Reference><Reference><Citation>Boileau A, Somoza AS, Dankiewicz J, Stammet P, Gilje P, Erlinge D, Hassager C, Wise MP, Kuiper M, Friberg H, Nielsen N, Devaux Y, TTM-Trial Investigators on behalf of Cardiolinc Network (2019) Circulating levels of miR-574-5p are associated with neurological outcome after cardiac arrest in women: a target temperature management (TTM) trial substudy. Dis Markers 2019:1802879</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6589199</ArticleId><ArticleId IdType="pubmed">31275442</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux Y, Dankiewicz J, Salgado-Somoza A, Stammet P, Collignon O, Gilje P, Gidlof O, Zhang L, Vausort M, Hassager C, Wise MP, Kuiper M, Friberg H, Cronberg T, Erlinge D, Nielsen N (2016) Association of circulating MicroRNA-124-3p levels with outcomes after out-of-hospital cardiac arrest: a substudy of a randomized clinical trial. JAMA Cardiol 1:305–313</Citation><ArticleIdList><ArticleId IdType="pubmed">27438111</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux Y, Salgado-Somoza A, Dankiewicz J, Boileau A, Stammet P, Schritz A, Zhang L, Vausort M, Gilje P, Erlinge D, Hassager C, Wise MP, Kuiper M, Friberg H, Nielsen N (2017) Incremental value of circulating MiR-122-5p to predict outcome after out of hospital cardiac arrest. Theranostics 7:2555–2564</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5558552</ArticleId><ArticleId IdType="pubmed">28819446</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanizzi FM, Nielsen N, Zhang L, Dankiewicz J, Stammet P, Gilje P, Erlinge D, Hassager C, Wise MP, Kuiper M, Friberg H, Devaux Y, Salgado-Somoza A (2020) Circulating levels of brain-enriched MicroRNAs Correlate with neuron specific enolase after cardiac arrest-A substudy of the target temperature management trial. Int J Mol Sci 21:4353</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7352657</ArticleId><ArticleId IdType="pubmed">32575355</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilje P, Gidlof O, Rundgren M, Cronberg T, Al-Mashat M, Olde B, Friberg H, Erlinge D (2014) The brain-enriched microRNA miR-124 in plasma predicts neurological outcome after cardiac arrest. Crit Care 18:R40</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4057474</ArticleId><ArticleId IdType="pubmed">24588965</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen H, Zaitseva D, Yang Z, Forsythe L, Joergensen S, Zone AI, Shehu J, Maghraoui S, Ghorbani A, Davila A, Issadore D, Abella BS (2023) Brain-derived extracellular vesicles as serologic markers of brain injury following cardiac arrest: a pilot feasibility study. Resuscitation 191:109937</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10528050</ArticleId><ArticleId IdType="pubmed">37591443</ArticleId></ArticleIdList></Reference><Reference><Citation>Carter AC, Chang HY, Church G, Dombkowski A, Ecker JR, Gil E, Giresi PG, Greely H, Greenleaf WJ, Hacohen N, He C, Hill D, Ko J, Kohane I, Kundaje A, Palmer M, Snyder MP, Tung J, Urban A, Vidal M, Wong W (2017) Challenges and recommendations for epigenomics in precision health. Nat Biotechnol 35:1128–1132</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5821229</ArticleId><ArticleId IdType="pubmed">29220033</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux Y (2022) MicroRNAs as biomarkers in the brain-heart axis? Eur Heart J Acute Cardiovasc Care 11:617–619</Citation><ArticleIdList><ArticleId IdType="pubmed">35816291</ArticleId></ArticleIdList></Reference><Reference><Citation>Caporali A, Anwar M, Devaux Y, Katare R, Martelli F, Srivastava PK, Pedrazzini T, Emanueli C (2024) Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease. Nat Rev Cardiol. 10.1038/s41569-024-01001-5</Citation><ArticleIdList><ArticleId IdType="pubmed">38499868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabov V, Gombozhapova A, Litviakov N, Ibragimova M, Tsyganov M, Rogovskaya Y, Kzhyshkowska J (2023) Microarray analysis for transcriptomic profiling of myocardium in patients with fatal myocardial infarction. Biomedicines 11:3294</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10740899</ArticleId><ArticleId IdType="pubmed">38137515</ArticleId></ArticleIdList></Reference><Reference><Citation>Miranda AMA, Janbandhu V, Maatz H, Kanemaru K, Cranley J, Teichmann SA, Hubner N, Schneider MD, Harvey RP, Noseda M (2023) Single-cell transcriptomics for the assessment of cardiac disease. Nat Rev Cardiol 20:289–308</Citation><ArticleIdList><ArticleId IdType="pubmed">36539452</ArticleId></ArticleIdList></Reference><Reference><Citation>Burdick JT, Comai A, Bruzel A, Sun G, Dedon PC, Cheung VG (2023) Nanopore-based direct sequencing of RNA transcripts with 10 different modified nucleotides reveals gaps in existing technology. G3 (Bethesda) 13:jka200</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10627276</ArticleId><ArticleId IdType="pubmed">37655917</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanizzi FM, Zhang L, Salgado-Somoza A, Dankiewicz J, Stammet P, Hassager C, Wise MP, Friberg H, Cronberg T, Hundt A, Kjaergaard J, Nielsen N, Devaux Y (2022) Circular RNAs to predict clinical outcome after cardiac arrest. Intensive Care Med Exp 10:41</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9613847</ArticleId><ArticleId IdType="pubmed">36303007</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Liu C, Niu Z, Li M, Zhang Y, Gao R, Chen H, Wang Q, Zhang S, Zhou R, Gan L, Zhang Z, Zhu T, Yu H, Liu J (2020) RNA-seq analysis of the key long noncoding RNAs and mRNAs related to cognitive impairment after cardiac arrest and cardiopulmonary resuscitation. Aging (Albany NY) 12:14490–14505</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7425488</ArticleId><ArticleId IdType="pubmed">32693388</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Qin Y, Liu X, Chen J, Tang A, Yan S, Zhang G (2023) Identification of predictors for neurological outcome after cardiac arrest in peripheral blood mononuclear cells through integrated bioinformatics analysis and machine learning. Funct Integr Genomics 23:83</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10023777</ArticleId><ArticleId IdType="pubmed">36930329</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopic M, Stopa V, Devaux Y (2024) Leveraging epitranscriptomics for cardiovascular disease theranostics. Eur Heart J. 10.1093/eurheartj/ehad852</Citation><ArticleIdList><ArticleId IdType="pubmed">38190430</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain M, Abu-Shumays R, Olsen HE, Akeson M (2022) Advances in nanopore direct RNA sequencing. Nat Methods 19:1160–1164</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11388133</ArticleId><ArticleId IdType="pubmed">36203024</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweaad WK, Stefanizzi FM, Chamorro-Jorganes A, Devaux Y, Emanueli C, EU-CardioRNA COST Action CA17129 (2021) Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system. J Mol Cell Cardiol 160:56–70</Citation><ArticleIdList><ArticleId IdType="pubmed">33991529</ArticleId></ArticleIdList></Reference><Reference><Citation>Karagianni K, Bibi A, Made A, Acharya S, Parkkonen M, Barbalata T, Srivastava PK, de Gonzalo-Calvo D, Emanueli C, Martelli F, Devaux Y, Dafou D, Nossent AY, CA EU-CCA (2024) Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases. Mol Ther Nucleic Acids 35:102085</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10772297</ArticleId><ArticleId IdType="pubmed">38192612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates JR III (2011) A century of mass spectrometry: from atoms to proteomes. Nat Methods 8:633–637</Citation></Reference><Reference><Citation>Stammet P, Collignon O, Hassager C, Wise MP, Hovdenes J, Åneman A, Horn J, Devaux Y, Erlinge D, Kjaergaard J (2015) Neuron-specific enolase as a predictor of death or poor neurological outcome after out-of-hospital cardiac arrest and targeted temperature management at 33 C and 36 C. J Am Coll Cardiol 65:2104–2114</Citation><ArticleIdList><ArticleId IdType="pubmed">25975474</ArticleId></ArticleIdList></Reference><Reference><Citation>Mörtberg E, Zetterberg H, Nordmark J, Blennow K, Rosengren L, Rubertsson S (2011) S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment. Resuscitation 82:26–31</Citation><ArticleIdList><ArticleId IdType="pubmed">21071131</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur G, Poljak A, Ali SA, Zhong L, Raftery MJ, Sachdev P (2021) Extending the depth of human plasma proteome coverage using simple fractionation techniques. J Proteome Res 20:1261–1279</Citation><ArticleIdList><ArticleId IdType="pubmed">33471535</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubarev RA, Makarov A (2013) Orbitrap mass spectrometry. In: Editor (ed)^(eds) Book Orbitrap mass spectrometry. ACS Publications, City</Citation></Reference><Reference><Citation>Ss Gu, Li J, Jiang M, Zhou Y, Yang B, Xie K, Yf J, Xr J, He F, Wang J (2021) Serum proteomic analysis of novel predictive serum proteins for neurological prognosis following cardiac arrest. J Cell Mol Med 25:1290–1298</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7812277</ArticleId><ArticleId IdType="pubmed">33336526</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung YS, Kwon WY, Suh GJ, Moon S, Han M-H, Youn J-I, Seo S-U, Kim KS, Seong S-Y (2018) Low serum Kallistatin level was associated with poor neurological outcome of out-of-hospital cardiac arrest survivors: proteomics study. Resuscitation 128:6–10</Citation><ArticleIdList><ArticleId IdType="pubmed">29698750</ArticleId></ArticleIdList></Reference><Reference><Citation>Distelmaier K, Muqaku B, Wurm R, Arfsten H, Seidel S, Kovacs GG, Mayer RL, Szekeres T, Wallisch C, Hubner P (2020) Proteomics-enriched prediction model for poor neurologic outcome in cardiac arrest survivors. Crit Care Med 48:167–175</Citation><ArticleIdList><ArticleId IdType="pubmed">31939784</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd JG, Smithson LJ, Howes D, Muscedere J, Kawaja MD, Group CCCTB (2016) Serum proteomics as a strategy to identify novel biomarkers of neurologic recovery after cardiac arrest: a feasibility study. Intensiv Care Med Exp 4:1–11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4864914</ArticleId><ArticleId IdType="pubmed">27165192</ArticleId></ArticleIdList></Reference><Reference><Citation>Lileikyte G, Bakochi A, Ali A, Moseby-Knappe M, Cronberg T, Friberg H, Lilja G, Levin H, Årman F, Kjellström S (2023) Serum proteome profiles in patients treated with targeted temperature management after out-of-hospital cardiac arrest. Intensive Care Med Exp 11:43</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10350448</ArticleId><ArticleId IdType="pubmed">37455296</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud J, Ong HTM, Ates E, Seo HS, Kang M-J (2023) Discovery of 14-3-3 zeta as a potential biomarker for cardiac hypertrophy. BMB Rep 56:341</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10315568</ArticleId><ArticleId IdType="pubmed">36977605</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao G, Xing J, Xiao X, Liou AK, Gao Y, Yin X-M, Clark RS, Graham SH, Chen J (2007) Critical role of calpain I in mitochondrial release of apoptosis-inducing factor in ischemic neuronal injury. J Neurosci 27:9278–9293</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6673113</ArticleId><ArticleId IdType="pubmed">17728442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wishart DS, Guo A, Oler E, Wang F, Anjum A, Peters H, Dizon R, Sayeeda Z, Tian S, Lee BL (2022) HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res 50:D622–D631</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728138</ArticleId><ArticleId IdType="pubmed">34986597</ArticleId></ArticleIdList></Reference><Reference><Citation>Beske RP, Henriksen HH, Obling L, Kjærgaard J, Bro-Jeppesen J, Nielsen N, Johansson PI, Hassager C (2022) Targeted plasma metabolomics in resuscitated comatose out-of-hospital cardiac arrest patients. Resuscitation 179:163–171</Citation><ArticleIdList><ArticleId IdType="pubmed">35753507</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoaib M, Choudhary RC, Choi J, Kim N, Hayashida K, Yagi T, Yin T, Nishikimi M, Stevens JF, Becker LB (2020) Plasma metabolomics supports the use of long-duration cardiac arrest rodent model to study human disease by demonstrating similar metabolic alterations. Sci Rep 10:19707</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665036</ArticleId><ArticleId IdType="pubmed">33184308</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C-L, Tsai M-S, Kuo C-H, Chou T-H, Chen W-J, Huang C-H (2018) Metabolomic profiling for outcome prediction in emergency department patients with out-of-hospital cardiac arrest. Resuscitation 123:e1–e2</Citation><ArticleIdList><ArticleId IdType="pubmed">29253647</ArticleId></ArticleIdList></Reference><Reference><Citation>Nummela AJ, Scheinin H, Perola M, Joensuu A, Laitio R, Arola O, Gronlund J, Roine RO, Backlund M, Vahlberg TJ, Laitio T, Xe-Hypotheca Collaboration G (2024) A metabolic profile of xenon and metabolite associations with 6-month mortality after out-of-hospital cardiac arrest: a post-hoc study of the randomised Xe-Hypotheca trial. PLoS ONE 19:e0304966</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11149864</ArticleId><ArticleId IdType="pubmed">38833442</ArticleId></ArticleIdList></Reference><Reference><Citation>Beske RP, Obling LER, Bro-Jeppesen J, Nielsen N, Meyer MAS, Kjaergaard J, Johansson PI, Hassager C (2023) The effect of targeted temperature management on the metabolome following out-of-hospital cardiac arrest. Ther Hypothermia Temperat Manag 13:208–215</Citation><ArticleIdList><ArticleId IdType="pubmed">37219970</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolan JP, Sandroni C, Bottiger BW, Cariou A, Cronberg T, Friberg H, Genbrugge C, Haywood K, Lilja G, Moulaert VRM, Nikolaou N, Mariero Olasveengen T, Skrifvars MB, Taccone F, Soar J (2021) European resuscitation council and European society of intensive care medicine guidelines 2021: post-resuscitation care. Resuscitation 161:220–269</Citation><ArticleIdList><ArticleId IdType="pubmed">33773827</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez Soto C, Dragoi L, Heyn CC, Kramer A, Pinto R, Adhikari NK, Scales DC (2020) Imaging for neuroprognostication after cardiac arrest: systematic review and meta-analysis. Neurocrit Care 32:206–216</Citation><ArticleIdList><ArticleId IdType="pubmed">31549351</ArticleId></ArticleIdList></Reference><Reference><Citation>Velly L, Perlbarg V, Boulier T, Adam N, Delphine S, Luyt CE, Battisti V, Torkomian G, Arbelot C, Chabanne R, Jean B, Di Perri C, Laureys S, Citerio G, Vargiolu A, Rohaut B, Bruder N, Girard N, Silva S, Cottenceau V, Tourdias T, Coulon O, Riou B, Naccache L, Gupta R, Benali H, Galanaud D, Puybasset L, Investigators M-C (2018) Use of brain diffusion tensor imaging for the prediction of long-term neurological outcomes in patients after cardiac arrest: a multicentre, international, prospective, observational, cohort study. Lancet Neurol 17:317–326</Citation><ArticleIdList><ArticleId IdType="pubmed">29500154</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva S, Peran P, Kerhuel L, Malagurski B, Chauveau N, Bataille B, Lotterie JA, Celsis P, Aubry F, Citerio G, Jean B, Chabanne R, Perlbarg V, Velly L, Galanaud D, Vanhaudenhuyse A, Fourcade O, Laureys S, Puybasset L (2017) Brain gray matter mri morphometry for neuroprognostication after cardiac arrest. Crit Care Med 45:e763–e771</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515639</ArticleId><ArticleId IdType="pubmed">28272153</ArticleId></ArticleIdList></Reference><Reference><Citation>Westhall E, Rossetti AO, van Rootselaar AF, Wesenberg Kjaer T, Horn J, Ullen S, Friberg H, Nielsen N, Rosen I, Aneman A, Erlinge D, Gasche Y, Hassager C, Hovdenes J, Kjaergaard J, Kuiper M, Pellis T, Stammet P, Wanscher M, Wetterslev J, Wise MP, Cronberg T (2016) Standardized EEG interpretation accurately predicts prognosis after cardiac arrest. Neurology 86:1482–1490</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4836886</ArticleId><ArticleId IdType="pubmed">26865516</ArticleId></ArticleIdList></Reference><Reference><Citation>Turella S, Dankiewicz J, Friberg H, Jakobsen JC, Leithner C, Levin H, Lilja G, Moseby-Knappe M, Nielsen N, Rossetti AO, Sandroni C, Zubler F, Cronberg T, Westhall E (2024) The predictive value of highly malignant EEG patterns after cardiac arrest: evaluation of the ERC-ESICM recommendations. Intensiv Care Med 50:90–102</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10811097</ArticleId><ArticleId IdType="pubmed">38172300</ArticleId></ArticleIdList></Reference><Reference><Citation>Aalberts N, Westhall E, Johnsen B, Hahn K, Kenda M, Cronberg T, Friberg H, Preuss S, Ploner CJ, Storm C, Nee J, Leithner C, Endisch C (2023) Cortical somatosensory evoked potential amplitudes and clinical outcome after cardiac arrest: a retrospective multicenter study. J Neurol 270:5999–6009</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10632270</ArticleId><ArticleId IdType="pubmed">37639017</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso L, Oddo M, Minini A, Citerio G, Horn J, Di Bernardini E, Rundgren M, Cariou A, Payen JF, Storm C, Stammet P, Sandroni C, Taccone FS (2022) Neurological pupil index and its association with other prognostic tools after cardiac arrest: a post hoc analysis. Resuscitation 179:259–266</Citation><ArticleIdList><ArticleId IdType="pubmed">35914656</ArticleId></ArticleIdList></Reference><Reference><Citation>Oddo M, Sandroni C, Citerio G, Miroz JP, Horn J, Rundgren M, Cariou A, Payen JF, Storm C, Stammet P, Taccone FS (2018) Quantitative versus standard pupillary light reflex for early prognostication in comatose cardiac arrest patients: an international prospective multicenter double-blinded study. Intensiv Care Med 44:2102–2111</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6280828</ArticleId><ArticleId IdType="pubmed">30478620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandroni C, D’Arrigo S, Cacciola S, Hoedemaekers CWE, Westhall E, Kamps MJA, Taccone FS, Poole D, Meijer FJA, Antonelli M, Hirsch KG, Soar J, Nolan JP, Cronberg T (2022) Prediction of good neurological outcome in comatose survivors of cardiac arrest: a systematic review. Intensiv Care Med 48:389–413</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8940794</ArticleId><ArticleId IdType="pubmed">35244745</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagebrant A, Lang M, Nielsen N, Blennow K, Dankiewicz J, Friberg H, Hassager C, Horn J, Kjaergaard J, Kuiper MA, Mattsson-Carlgren N, Pellis T, Rylander C, Sigmund R, Stammet P, Unden J, Zetterberg H, Wise MP, Cronberg T, Moseby-Knappe M (2023) Brain injury markers in blood predict signs of hypoxic ischaemic encephalopathy on head computed tomography after cardiac arrest. Resuscitation 184:109668</Citation><ArticleIdList><ArticleId IdType="pubmed">36563954</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu M, Snyder M (2023) Multi-omics profiling for health. Mol Cell Proteomics 22:100561</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220275</ArticleId><ArticleId IdType="pubmed">37119971</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffens S, Schroder K, Kruger M, Maack C, Streckfuss-Bomeke K, Backs J, Backofen R, Baessler B, Devaux Y, Gilsbach R, Heijman J, Knaus J, Kramann R, Linz D, Lister AL, Maatz H, Maegdefessel L, Mayr M, Meder B, Nussbeck SY, Rog-Zielinska EA, Schulz MH, Sickmann A, Yigit G, Kohl P (2024) The challenges of research data management in cardiovascular science: a DGK and DZHK position paper-executive summary. Clin Res Cardiol 113:672–679</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11026239</ArticleId><ArticleId IdType="pubmed">37847314</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim SY, Selvaraji S, Lau H, Li SFY (2022) Application of omics beyond the central dogma in coronary heart disease research: a bibliometric study and literature review. Comput Biol Med 140:105069</Citation><ArticleIdList><ArticleId IdType="pubmed">34847384</ArticleId></ArticleIdList></Reference><Reference><Citation>Sopic M, Vilne B, Gerdts E, Trindade F, Uchida S, Khatib S, Wettinger SB, Devaux Y, Magni P, CA EU-ACA (2023) Multiomics tools for improved atherosclerotic cardiovascular disease management. Trends Mol Med 29:983–995</Citation><ArticleIdList><ArticleId IdType="pubmed">37806854</ArticleId></ArticleIdList></Reference><Reference><Citation>Badimon L, Robinson EL, Jusic A, Carpusca I, deWindt LJ, Emanueli C, Ferdinandy P, Gu W, Gyongyosi M, Hackl M, Karaduzovic-Hadziabdic K, Lustrek M, Martelli F, Nham E, Potocnjak I, Satagopam V, Schneider R, Thum T, Devaux Y (2021) Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovasc Res 117:1823–1840</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083253</ArticleId><ArticleId IdType="pubmed">33839767</ArticleId></ArticleIdList></Reference><Reference><Citation>Devaux Y, Zhang L, Lumley AI, Karaduzovic-Hadziabdic K, Mooser V, Rousseau S, Shoaib M, Satagopam V, Adilovic M, Srivastava PK, Emanueli C, Martelli F, Greco S, Badimon L, Padro T, Lustrek M, Scholz M, Rosolowski M, Jordan M, Brandenburger T, Benczik B, Agg B, Ferdinandy P, Vehreschild JJ, Lorenz-Depiereux B, Dorr M, Witzke O, Sanchez G, Kul S, Baker AH, Fagherazzi G, Ollert M, Wereski R, Mills NL, Firat H (2024) Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality. Nat Commun 15:4259</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11106268</ArticleId><ArticleId IdType="pubmed">38769334</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed Z (2022) Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities. Emerg Top Life Sci 6:215–225</Citation><ArticleIdList><ArticleId IdType="pubmed">35234253</ArticleId></ArticleIdList></Reference><Reference><Citation>Acharya S, Das S, Devaux Y, Robinson EL (2024) The impact of government policies, funding, and networking to accelerate transatlantic cardiovascular research. Eur Heart J 45:567–569</Citation><ArticleIdList><ArticleId IdType="pubmed">38103179</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>